Copy of `AGNIC - Wildlife terms`
The wordlist doesn't exist anymore, or, the website doesn't exist anymore. On this page you can find a copy of the original information. The information may have been taken offline because it is outdated.
|
|
AGNIC - Wildlife terms
Category: Animals and Nature > Wildlife Management
Date & country: 27/09/2013, USA Words: 917
|
rbcred blood cell. See erythrocyte.
rbvsee ribavirin.
reactivationthe return of a previously latent (inactive) infection to an active, pathogenic state.
rebetolSchering
rebetrona bundled kit for HCV treatment that packages together Intron-A brand interferon and ribavirin.
reboundan increase in viral load following a previous decrease.
receptora specific binding site on a cell's surface or in its interior. When chemical messengers or drugs bind to receptors, various cellular functions are activated or inhibited. Viruses must bind receptors in order to enter cells.
recombinantproduced by genetic engineering.
reconstitutionmixing a substance (e.g., Peg-Intron brand pegylated interferon) with water to return it to a usable form.
recruitmentthe period of time assigned to identify and enroll in a clinical trial.
recurrentreturning or occurring repeatedly.
red blood cellsee erythrocyte.
reflexologyan alternative healing technique that involves putting pressure on various zones of the body.
refractoryresistant to treatment.
regenerationregrowth.
regimena specific treatment protocol, including what drugs are taken and at what dosages.
reikia healing technique in which energy is channeled through the hands of the healer.
reiter's syndromesee reactive arthritis.
relapserecurrence of disease symptoms following a period of improvement. In HCV, relapse can refer to an increase in viral load after it has been suppressed.
relapsera person who becomes HCV RNA negative at end of treatment, but becomes HCV detectable within 24 weeks from the end of treatment (EOT).
renalhaving to do with the kidneys.
replicationmultiplication or reproduction, specifically used when referring to a virus.
resectionsee hepatic resection.
resistancethe mutation of a microorganism in such a way that it loses its sensitivity to a drug; a resistant organism can function and replicate despite the drug's presence.
resolvewhen referring to a condition, to clear up or heal.
responder-relapsera person who initially responds well to a treatment, but then experiences a relapse. In chronic HCV infection, this refers to a person who initially has a positive response to treatment (e.g., normal ALT, undetectable HCV RNA), but does not sustain this response once treatment is stopped.
response to treatmentsee treatment response.
response-guided treatmentResponse-guided therapy uses HCV RNA testing during treatment to predict response and guide treatment duration for patients with chronic hepatitis C.
retinopathydisease of the retina of the eye.
retrospective studya study based on medical records, looking backward in time at events that happened in the past. Contrast with prospective study.
retrovirusa class of viruses that have their genetic material in the form of RNA and use the reverse transcriptase enzyme to transcribe their RNA into DNA within the host cell.
rheumatoid arthritis (ra)an autoimmune condition characterized by joint inflammation and destruction of connective tissue; other organs, including the heart, lungs, kidneys, and skin, may also be affected.
rheumatoid factora type of antibody (IgM) that reacts to abnormal IgG antibodies produced by people with autoimmune conditions such as rheumatoid arthritis.
rheumatologythe study and treatment of conditions of the joints, muscles, bones, and connective tissues.
ribaa type of antibody test; RIBA is often used to confirm HCV antibody positivity detected on an ELISA II test.
ribasphereKadmon Pharmaceutical
ribavirin (rbv)an antiviral medication approved for use in combination with interferon to treat chronic HCV infection.
ribonucleic acid (rna)a single-stranded nucleic acid that encodes genetic information. The presence of viral RNA in the blood indicates that a virus is actively replicating. Hepatitis C and HIV are examples of RNA viruses.
ribozymean RNA molecule that cleaves (cuts) RNA strands at a specific site. A ribozyme directed against a specific region of the HCV genome is currently under study as a treatment for HCV.
rimantadine (brand name flumadine)a drug used to treat influenza that is also under study as a treatment for chronic hepatitis C.
risk/benefit ratioa measurement used to evaluate whether potential benefits outweigh potential risks (e.g., in a clinical trial).
rnasee ribonucleic acid.
roferon-abrand name of interferon-alpha-2a, produced by Roche Laboratories.
rxtreatment
safer sexsexual activities that reduce or eliminate the spread of sexually transmitted diseases, typically by blocking contact with semen and/or vaginal fluid.
salvage therapyemergency treatment with experimental drugs for an illness that does not respond to standard therapy.
sam-esee s-adenosylmethionine.
sample sizethe number of participants in a clinical trial.
sarcoidosisan autoimmune condition characterized by granulomas (small nodules of cells); the condition may affect the lungs, skin, eyes, liver, and other organs.
sargramostimsee granulocyte colony-stimulating factor.
schisandra (wu wei zi)a plant used in traditional Chinese and Russian medicine to treat liver conditions.
sclerodermaan autoimmune condition characterized by hardened skin and connective tissue.
seizurea burst of abnormal electrical activity in the brain.
seleniuma trace mineral that acts as an antioxidant.
semenmale ejaculatory fluid containing sperm and various proteins.
sensitivitythe ability of an organism to respond to a drug or other agent. Sensitivity also refers to a statistical measure of the accuracy of a screening test, that is, how likely a test is to label as positive those who have a disease or condition. Contrast with specificity.
sepsisinfection.
seroconversionthe development of antibodies against a pathogen; the change in a person's antibody status from negative to positive.
seronegativelack of antibodies against a pathogen in the blood.
seropositivepresence of antibodies against a pathogen in the blood.
serostatusthe presence or absence of antibodies against a pathogen in the blood.
serumthe fluid, noncellular portion of blood that remains after coagulation; lymphatic fluid. See also plasma.
serum hepatitissee hepatitis B.
sgotserum oxaloacetic transaminase. See aspartate aminotransferase.
sgptserum glutamic pyruvic transaminase. See alanine aminotransferase.
sheddingrelease of infectious particles (e.g., bacteria, viruses) into the environment.
sho-saiko-toa traditional herbal liver formula containing bupleurum.
sialadenitisSialadenitis is an inflammatory disease that causes dry mouth and eyes and is associated with hepatitis C infection. Sialadenitis destroys the salivary glands.
side effectsee adverse reaction.
silibinan active component of milk thistle.
silymarinsee milk thistle.
sinusoidscavities through hepatic or liver tissue allowing exchange of nutrients and other substances between blood and hepatocytes (liver cells).
sjan autoimmune disorder in which the immune system attacks fluid-producing exocrine glands, leading to dry eyes, mouth, vagina, etc.
socsee standard of care
sodiuman element and electrolyte and a component of salt that helps to regulate cell fluid balance.
specificitya statistical measure of the accuracy of a screening test. Specificity measures the proportion of negatives which are correctly identified (e.g., the percentage of healthy people who are correctly identified as not having the condition). Contrast with sensitivity.
spider angiomaa mass of visible veins on the skin surface; may be a symptom of chronic liver damage.
splenomegalyenlargement of the spleen.
spontaneous bacterial peritontisbacterial infection of ascitic fluid in the abdominal cavity.
sqsee subcutaneous.
ssrisee selective serotonin reuptake inhibitor.
stage ithe earliest stage of liver damage, characterized by liver inflammation without fibrosis or cirrhosis.
stage iia stage of liver damage characterized by fibrosis in a single area of the liver.
stage iiia stage of liver damage characterized by fibrosis in adjacent areas of the liver.
stage ivthe most advanced stage of liver damage, characterized by cirrhosis and loss of normal liver architecture.
standard interferonthe type of interferon-alpha traditionally used to treat HCV. Brand names include Intron-A and Roferon-A. Also see pegylated interferon.
standard of carethe level of care that all persons with a particular illness should receive; the level below which care would be considered substandard.
standard therapythe best or most widely used currently available treatment for a disease.
statistical significancethe probability that a clinical trial result is not due to chance alone. In general, a result of a clinical trial is considered statistically significant if there is a less than 5% probability that the difference observed would occur by chance alone if the treatments being compared were equally effective.
stdsee sexually transmitted disease.
steatosisbuildup of fat tissue in the liver.
stenosisnarrowing or tightening of an opening or passage in the body.
steroida family of substances that share a similar chemical structure, including certain hormones (e.g., testosterone) and various drugs.
stisee sexually transmitted disease.
stroke (cerebrovascular accident)interruption of the normal flow of blood to the brain due to a blood clot or hemorrhage. Lack of blood flow can lead to brain damage (resulting in symptoms such paralysis) and death.
subclinicaldisease symptoms that are too subtle to be noticed by a patient, but may be apparent in laboratory results.
subcutaneous (sq)underneath the skin; usually refers to a drug injected under the skin.
subjecta volunteer participant in a clinical trial.
subtherapeutica drug dosage that is too low to be effective.
subtypea genetic variation of an organism. Subtypes are a more narrow classification than genotypes, but broader than quasispecies. Genotype 1 HCV is divided into subtypes 1a and 1b.